Urinary sodium and potassium excretion, mortality, and cardiovascular events
BACKGROUND: The optimal range of sodium intake for cardiovascular health is controversial. METHODS: We obtained morning fasting urine samples from 101,945 persons in 17 countries and estimated 24-hour sodium and potassium excretion (used as a surrogate for intake). We examined the association betwee...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Massachussetts Medical Society
2014
|
Subjects: | |
Online Access: | View Fulltext in Publisher View in Scopus |
LEADER | 05390nam a2201117Ia 4500 | ||
---|---|---|---|
001 | 10.1056-NEJMoa1311889 | ||
008 | 220112s2014 CNT 000 0 und d | ||
020 | |a 00284793 (ISSN) | ||
245 | 1 | 0 | |a Urinary sodium and potassium excretion, mortality, and cardiovascular events |
260 | 0 | |b Massachussetts Medical Society |c 2014 | |
856 | |z View Fulltext in Publisher |u https://doi.org/10.1056/NEJMoa1311889 | ||
856 | |z View in Scopus |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906080079&doi=10.1056%2fNEJMoa1311889&partnerID=40&md5=428bb003cbc46430a74028447ea5ded8 | ||
520 | 3 | |a BACKGROUND: The optimal range of sodium intake for cardiovascular health is controversial. METHODS: We obtained morning fasting urine samples from 101,945 persons in 17 countries and estimated 24-hour sodium and potassium excretion (used as a surrogate for intake). We examined the association between estimated urinary sodium and potassium excretion and the composite outcome of death and major cardiovascular events. RESULTS: The mean estimated sodium and potassium excretion was 4.93 g per day and 2.12 g per day, respectively. With a mean follow-up of 3.7 years, the composite outcome occurred in 3317 participants (3.3%). As compared with an estimated sodium excretion of 4.00 to 5.99 g per day (reference range), a higher estimated sodium excretion (≥7.00 g per day) was associated with an increased risk of the composite outcome (odds ratio, 1.15; 95% confidence interval [CI], 1.02 to 1.30), as well as increased risks of death and major cardiovascular events considered separately. The association between a high estimated sodium excretion and the composite outcome was strongest among participants with hypertension (P=0.02 for interaction), with an increased risk at an estimated sodium excretion of 6.00 g or more per day. As compared with the reference range, an estimated sodium excretion that was below 3.00 g per day was also associated with an increased risk of the composite outcome (odds ratio, 1.27; 95% CI, 1.12 to 1.44). As compared with an estimated potassium excretion that was less than 1.50 g per day, higher potassium excretion was associated with a reduced risk of the composite outcome. CONCLUSIONS: In this study in which sodium intake was estimated on the basis of measured urinary excretion, an estimated sodium intake between 3 g per day and 6 g per day was associated with a lower risk of death and cardiovascular events than was either a higher or lower estimated level of intake. As compared with an estimated potassium excretion that was less than 1.50 g per day, higher potassium excretion was associated with a lower risk of death and cardiovascular events. Copyright © 2014 Massachusetts Medical Society. | |
650 | 0 | 4 | |a adult |
650 | 0 | 4 | |a Adult |
650 | 0 | 4 | |a aged |
650 | 0 | 4 | |a article |
650 | 0 | 4 | |a cardiovascular disease |
650 | 0 | 4 | |a Cardiovascular Diseases |
650 | 0 | 4 | |a cardiovascular mortality |
650 | 0 | 4 | |a cardiovascular risk |
650 | 0 | 4 | |a cerebrovascular accident |
650 | 0 | 4 | |a cohort analysis |
650 | 0 | 4 | |a controlled clinical trial |
650 | 0 | 4 | |a controlled study |
650 | 0 | 4 | |a diastolic blood pressure |
650 | 0 | 4 | |a diet |
650 | 0 | 4 | |a Diet |
650 | 0 | 4 | |a disease association |
650 | 0 | 4 | |a female |
650 | 0 | 4 | |a Female |
650 | 0 | 4 | |a follow up |
650 | 0 | 4 | |a Follow-Up Studies |
650 | 0 | 4 | |a heart failure |
650 | 0 | 4 | |a heart infarction |
650 | 0 | 4 | |a high risk population |
650 | 0 | 4 | |a human |
650 | 0 | 4 | |a Humans |
650 | 0 | 4 | |a hypertension |
650 | 0 | 4 | |a Linear Models |
650 | 0 | 4 | |a low risk population |
650 | 0 | 4 | |a male |
650 | 0 | 4 | |a Male |
650 | 0 | 4 | |a middle aged |
650 | 0 | 4 | |a Middle Aged |
650 | 0 | 4 | |a mortality |
650 | 0 | 4 | |a Mortality |
650 | 0 | 4 | |a multicenter study |
650 | 0 | 4 | |a outcome assessment |
650 | 0 | 4 | |a potassium |
650 | 0 | 4 | |a Potassium |
650 | 0 | 4 | |a potassium excretion |
650 | 0 | 4 | |a potassium urine level |
650 | 0 | 4 | |a priority journal |
650 | 0 | 4 | |a prospective study |
650 | 0 | 4 | |a risk assessment |
650 | 0 | 4 | |a sodium |
650 | 0 | 4 | |a Sodium |
650 | 0 | 4 | |a sodium excretion |
650 | 0 | 4 | |a sodium intake |
650 | 0 | 4 | |a sodium urine level |
650 | 0 | 4 | |a Sodium, Dietary |
650 | 0 | 4 | |a statistical model |
650 | 0 | 4 | |a systolic blood pressure |
650 | 0 | 4 | |a urinalysis |
650 | 0 | 4 | |a urine |
700 | 1 | 0 | |a Avezum, A. |e author |
700 | 1 | 0 | |a Chifamba, J. |e author |
700 | 1 | 0 | |a Dagenais, G. |e author |
700 | 1 | 0 | |a Devanath, A. |e author |
700 | 1 | 0 | |a Diaz, R. |e author |
700 | 1 | 0 | |a Gulec, S. |e author |
700 | 1 | 0 | |a Ilow, R. |e author |
700 | 1 | 0 | |a Iqbal, R. |e author |
700 | 1 | 0 | |a Kabali, C. |e author |
700 | 1 | 0 | |a Kruger, L. |e author |
700 | 1 | 0 | |a Lanas, F. |e author |
700 | 1 | 0 | |a Lear, S.A. |e author |
700 | 1 | 0 | |a Lee, S.F. |e author |
700 | 1 | 0 | |a Liu, L. |e author |
700 | 1 | 0 | |a Lopez-Jaramillo, P. |e author |
700 | 1 | 0 | |a McQueen, M.J. |e author |
700 | 1 | 0 | |a Mente, A. |e author |
700 | 1 | 0 | |a Mohammadifard, N. |e author |
700 | 1 | 0 | |a Mony, P. |e author |
700 | 1 | 0 | |a O'Donnell, M. |e author |
700 | 1 | 0 | |a Rangarajan, S. |e author |
700 | 1 | 0 | |a Rosengren, A. |e author |
700 | 1 | 0 | |a Teo, K. |e author |
700 | 1 | 0 | |a Wang, X. |e author |
700 | 1 | 0 | |a Yan, H. |e author |
700 | 1 | 0 | |a Yusoff, K. |e author |
700 | 1 | 0 | |a Yusuf, R. |e author |
700 | 1 | 0 | |a Yusuf, S. |e author |
700 | 1 | 0 | |a Yusufali, A.H. |e author |
773 | |t New England Journal of Medicine |